Connect Biopharma (CNTB) Institutional Ownership $0.82 -0.03 (-3.96%) Closing price 03:59 PM EasternExtended Trading$0.80 -0.01 (-1.84%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Connect Biopharma (NASDAQ:CNTB)CurrentInstitutional OwnershipPercentage58.72%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$430.71KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$98.26K Get CNTB Insider Trade Alerts Want to know when executives and insiders are buying or selling Connect Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CNTB Institutional Buying and Selling by Quarter Connect Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Renaissance Technologies LLC134,697$186K0.0%-23.2%0.244% 2/3/2025 Callan Capital LLC80,000$110K0.0%+91.3%0.145% 1/27/2025 Choreo LLC160,867$204K0.0%N/A0.291% 1/24/2025 Catalina Capital Group LLC47,867$66K0.0%N/A0.087% 11/5/2024 BML Capital Management LLC2,093,232$3.01M1.8%+2.4%3.789% 8/9/2024 Renaissance Technologies LLC212,300$323K0.0%-11.5%0.385% 7/17/2024 Keudell Morrison Wealth Management32,200$49K0.0%+63.5%0.058% 5/7/2024 Keudell Morrison Wealth Management19,700$34K0.0%+75.9%0.036% 1/30/2024 BML Capital Management LLC2,061,438$2.43M1.8%N/A3.743% 8/15/2023 Kynam Capital Management LP535,005$603K0.1%-27.7%0.972% Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022 Boothbay Fund Management LLC26,867$35K0.0%-65.5%0.049% 8/16/2022 DAFNA Capital Management LLC250,000$218K0.1%N/A0.454% 5/13/2022 Kynam Capital Management LP227,759$688K0.2%N/A0.414% 2/22/2022 DLD Asset Management LP121,707$627K0.0%N/A0.212% 2/15/2022 DLD Asset Management LP121,707$627K0.0%N/A0.212% 2/15/2022 Adage Capital Partners GP L.L.C.1,250,000$6.44M0.0%N/A2.174% 2/14/2022 Altium Capital Management LP175,000$901K0.2%N/A0.304% 2/14/2022 Deep Track Capital LP647,057$3.33M0.2%N/A1.125% 2/11/2022 Ensign Peak Advisors Inc25,412$131K0.0%N/A0.044% 11/16/2021 Janus Henderson Group PLC403,459$9.57M0.0%+3.1%0.702% 11/16/2021 Wellington Management Group LLP1,145,177$27.37M0.0%-25.3%1.991% 11/12/2021Vident Investment Advisory LLC10,851$263K0.0%N/A0.019% 11/9/2021BlackRock Inc.2,450,065$59.37M0.0%-0.3%4.261% 11/5/2021 Daiwa Securities Group Inc.6,069$147K0.0%N/A0.011% 8/17/2021 Millennium Management LLC42,856$837K0.0%+286.1%0.075% 8/17/2021 Old Well Partners LLC122,431$2.39M1.1%N/A0.213% 8/16/2021 RA Capital Management L.P.6,991,003$136.53M2.2%+133.7%12.157% 8/16/2021 Federated Hermes Inc.12,000$234K0.0%-70.0%0.021% 8/13/2021 FMR LLC3,925,836$76.67M0.0%+23.3%6.827% 8/11/2021BlackRock Inc.2,458,132$48.01M0.0%+0.3%4.275% 8/10/2021 Citigroup Inc.1,413$28K0.0%N/A0.002% 5/19/2021 Logos Global Management LP150,000$2.78M0.3%N/A0.261% 5/19/2021 Octagon Capital Advisors LP373,492$6.91M2.6%N/A0.650% 5/18/2021 Millennium Management LLC11,099$205K0.0%N/A0.019% 5/18/2021 Zimmer Partners LP10,000$185K0.0%N/A0.017% 5/18/2021 RA Capital Management L.P.2,991,208$55.34M0.8%N/A5.202% 5/18/2021 State of Wisconsin Investment Board100,272$1.86M0.0%N/A0.174% 5/18/2021 Alyeska Investment Group L.P.50,000$925K0.0%N/A0.087% 5/18/2021Boxer Capital LLC2,081,323$38.50M1.3%N/A3.619% 5/18/2021 Cormorant Asset Management LP1,000,000$18.50M0.4%N/A1.739% Gold Hits New Highs as Global Markets Spiral (Ad)When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.Go Here to Learn What's Happening and How to Prepare >>5/18/2021 Citadel Advisors LLC245,191$4.54M0.0%N/A0.426% 5/17/2021 Point72 Hong Kong Ltd10,426$193K0.0%N/A0.018% 5/17/2021 Rock Springs Capital Management LP119,114$2.20M0.0%N/A0.207% 5/17/2021 DAFNA Capital Management LLC8,000$148K0.0%N/A0.014% 5/17/2021 Janus Henderson Group PLC475,000$8.70M0.0%N/A0.826% 5/17/2021Pinz Capital Management LP43,100$797K0.2%N/A0.075% 5/17/2021 Sphera Funds Management LTD.50,000$925K0.1%N/A0.087% 5/14/2021 RTW Investments LP450,000$8.33M0.1%N/A0.783% 5/14/2021 Monashee Investment Management LLC110,000$2.04M0.3%N/A0.191% 5/13/2021 Federated Hermes Inc.40,000$740K0.0%N/A0.070% (Data available from 1/1/2016 forward) CNTB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CNTB shares? During the previous two years, the following institutional investors and hedge funds held shares of Connect Biopharma shares: BML Capital Management LLC ($3.01M), Kynam Capital Management LP ($603K), Choreo LLC ($204K), Renaissance Technologies LLC ($186K), Callan Capital LLC ($110K), and Catalina Capital Group LLC ($66K), and Keudell Morrison Wealth Management ($49K).Learn more on CNTB's institutional investors. What percentage of Connect Biopharma stock is owned by institutional investors? 58.72% of Connect Biopharma stock is owned by institutional investors. Learn more on CNTB's institutional investor holdings. Which institutional investors have been buying Connect Biopharma stock? The following institutional investors have purchased Connect Biopharma stock in the last 24 months: BML Capital Management LLC ($2.11M), Choreo LLC ($160.87K), Catalina Capital Group LLC ($47.87K), Callan Capital LLC ($38.18K), and Keudell Morrison Wealth Management ($21K). How much institutional buying is happening at Connect Biopharma? Institutional investors have bought a total of 2,379,333 shares in the last 24 months. This purchase volume represents approximately $2.88M in transactions. Which Connect Biopharma major shareholders have been selling company stock? The following institutional investors have sold Connect Biopharma stock in the last 24 months: Kynam Capital Management LP ($204.64K), and Renaissance Technologies LLC ($68.40K). How much institutional selling is happening at Connect Biopharma? Institutional investors have sold a total of 273,047 shares in the last 24 months. This volume of shares sold represents approximately $329.51K in transactions. Related Companies PRME Institutional Ownership INMB Institutional Ownership TLSA Institutional Ownership MOLN Institutional Ownership ELDN Institutional Ownership OGI Institutional Ownership INBX Institutional Ownership PRQR Institutional Ownership HURA Institutional Ownership DMAC Institutional Ownership This page (NASDAQ:CNTB) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNTB Stock Free CNTB Stock Alerts